A Global Leader in Digital Diagnostics
Build next generation computational technology that unlocks insights from each sample for doctors to optimize patient outcomes.
Create a world where patients get deep, comprehensive insights into their biology, so diagnoses translate into effective, personalized treatments.
With a potential 60 percent increase in the number of cancer cases globally in the next two decades and a decrease in the number of pathologists relative to this diagnostic demand, the need to expedite advancements in pathology is pressing. This issue is further exacerbated by the fact that pathology — despite being the foundation of diagnosis — has yet to become digital.
Led by a team of experts in pathology, machine learning, healthcare, and business, Paige strives to make it possible to not only provide additional information from digital slides to help pathologists perform their diagnostic work efficiently and accurately, but also to go beyond this traditional work to extract new diagnostic information from pathology slides and patient samples that have the potential to support informed treatment pathways for patients. Paige technology is also helping life sciences companies evaluate and design personalized treatments for patients.
A Top-Notch Team Driven To Reimagine How Patients Are Diagnosed and Treated
Paige is being built by an outstanding group of experts in pathology, machine learning, healthcare, and business growth that come from leading companies and institutions like Arterys, Foundation Medicine, HeartFlow, Memorial Sloan Kettering Cancer Center, Merck, NASA, and NVIDIA.
- Leo Grady, PhD Chief Executive Officer
- Thomas Fuchs, Dr.Sc. Founder, Chief Scientist
- Carla Leibowitz Chief Business Development Officer
- Razik Yousfi Vice President of Engineering
- Jillian Sue Director of Product
- Chris Kanan, PhD Senior AI Scientist
- Brandon Rothrock, PhD Senior AI Scientist
- David S. Klimstra, MD
Chair, Department of Pathology, James Ewing Alumni Chair of Pathology, Memorial Sloan Kettering Cancer Center
- Jorge Reis-Filho, MD, PhD, FRCPath
Principal of Biomarker Development, Paige
Chief, Experimental Pathology Service, Memorial Sloan Kettering Cancer Center
- Carolyn Compton, MD Professor of Life Sciences, Arizona State University
- David Rimm, MD, PhD Professor of Pathology, Yale University School of Medicine
- Marc Ladanyi, MD Chief, Molecular Diagnostics Service, Memorial Sloan Kettering Cancer Center
- Alexander Lazar, MD, PhD Professor, Departments of Pathology and Genomic Medicine, The University of Texas MD Anderson Cancer Center
- Serge Belongie, PhD Andrew H. and Ann R. Tisch and Computer Science Professor, Cornell Tech and Cornell University
- John Iafrate, MD, PhD
Professor of Pathology, Harvard Medical School
Vice Chair for Academic Affairs, Massachusetts General Hospital Pathology Department
11 Times Square, Fl 37
New York, NY, 10036
In the heart of midtown Manhattan.